Skip to main content
Industries · Healthcare & Life Sciences

Find the cost and care patterns hidden in your claims

DecisionBox reads claims, member, clinical and prescriber data inside your own environment, and pinpoints the plan, provider or therapy driving a change, before the monthly review.

CriticalCost concentration

Pharmacy spend rose 4% in aggregate — DecisionBox surfaced a single therapeutic class driving most of it, concentrated in one plan segment.

Volume held flat; unit cost moved. The dashboard read total spend; the data read the class × plan segment carrying the entire shift, weeks before close.

RecommendationRoute the segment to pharmacy analytics for formulary review; surface the unit-cost driver in the next clinical committee.

Built for payers, providers, life sciences, and population health teams at health plans, PBMs, health systems, pharma, MedTech, ACOs, and value-based care organizations.

The cost of late signals

Aggregate metrics look fine. The cohort underneath is where the cost actually moved.

Three benchmarks every healthcare commercial and operational leader recognizes. Each points to the same gap: your data already holds the signals — cohort drift, cost concentrations, cross-system leakage — but they only surface when somebody asks the right question. Most months, nobody does.

Investment intent
85%

Of healthcare leaders plan to increase agentic AI investment in the next 2-3 years. The discovery loop is where the spend lands when it lands well — not in pilots that don't touch cost, quality, or outcomes.

Source: Deloitte, 2026 Global Healthcare Outlook
Already in motion
47%

Of healthcare and life sciences leaders are already using or assessing AI agents. Most efforts sit in narrow pilots; the cohort-level cost and quality work is where the broader budget moves next.

Source: NVIDIA, State of AI in Healthcare and Life Sciences
Adopter payoff gap
59%

Of early adopters expect cost savings above 20% — vs. only 13% of watchers. The gap shows up first at the cohort level, weeks before it shows up in the executive review.

Source: Deloitte, 2026 Global Healthcare Outlook
The shapes DecisionBox finds

From a finding to a plan

Three structural shapes DecisionBox finds across payer, provider, life sciences, and population health data: a single-cohort drift the aggregate concealed, a cross-system pattern the dashboard couldn't see, and an aggregate mirage that averaged two opposing shifts into a flat line. The shapes below are representative of what the engine surfaces; specific numbers come from the customer's own data.

CriticalCost concentration

Pharmacy spend moved in aggregate, but DecisionBox surfaced a single therapeutic class driving most of it, concentrated in one plan segment.

shape
aggregate spend up; segment-level unit cost up
dimensions cut
therapeutic class × plan × segment
competing causes ruled out
utilization volume, generic mix shift
signal precedes monthly close by
~2-3 weeks
P1Route to pharmacy analytics + clinical committee

Route the affected class × plan segment to pharmacy analytics for formulary review; surface the unit-cost driver in the next clinical committee; instrument segment-level spend alongside the aggregate KPI.

target
act on the cohort-level signal before close
effort
small (analytics handoff + committee surfacing)
HighCross-system leakage

Out-of-network referrals concentrated in two specialties for a specific payer mix. The retention dashboard couldn't see the pattern because the signal lived across three systems.

shape
leakage concentrated by specialty × payer mix
systems joined
EHR + referral system + claims
dimensions cut
specialty × payer × geography × PCP
pattern type
structural, not anecdotal
P1Route to network development + standing report

Route the affected referral pattern to network development for specialty-level contract review; instrument cross-system leakage by specialty and payer as a standing monthly report.

target
close the structural leakage before the next contract cycle
effort
medium (network development handoff + report build)
HighAggregate mirage

The latest formulary change showed neutral aggregate impact. The data read two opposing segment-level shifts — one absorbed it, one dropped persistence sharply.

shape
aggregate flat; two opposing segment moves
systems joined
claims + member + benefit + cost-share
dimensions cut
cost-share × plan type × geography × cohort
common failure mode
aggregate hides offsetting shifts
P1Treat the segments separately + instrument segment-level KPI

Treat the two segments separately in the next benefit committee; instrument segment-level persistence alongside the aggregate KPI; flag the change-impact decomposition as a standing post-implementation review.

target
stop averaging two populations into one signal
effort
small (committee surfacing + KPI add)
Built for every team

Same engine, different findings for every team.

Healthcare data is rarely owned by one team. DecisionBox runs against the same claims, member, clinical, and prescriber data — and tunes its discoveries to the team reading the output. Four teams, one engine, plus the cross-cutting capability that ties them together.

For health plans, PBMs, and TPAs — the medical-economics review, decomposed.

Built for actuarial, network, pharmacy, member analytics, fraud & abuse, and risk adjustment teams. DecisionBox reads claims, member, pharmacy, and network data together and surfaces the cohorts dragging the aggregate. The same engine that finds utilization spikes in a provider cohort after a network change finds pharmacy class drift in one segment, or coding gaps against the panel benchmark. The deep dive lives in how DecisionBox decides what to investigate.

Sample analysis areas
  • Utilization spikes concentrated in one provider cohort after a network or formulary change
  • Pharmacy spend drift — therapeutic classes moving in one segment without volume change
  • HCC coding gaps — provider groups under-coding vs. the panel benchmark
  • FWA signal — claim patterns inconsistent with procedure-norm distributions
  • Risk adjustment cohort accuracy against actuarial baseline
Why DecisionBox

Built for healthcare teams who want a cohort analyst running overnight, not three dashboards to reconcile.

Three things every finding from DecisionBox carries. None of them changes how your team works in your claims system, your EHR, your data platform, or whatever data tools and BI you already standardized on.

01

Sees what nobody had time to look into

DecisionBox picks which cohorts, providers, segments, and measures to investigate from your claims, member, clinical, and prescriber data. Findings ship into a queue your team triages in the morning. The cohort-level question stops sitting in the data waiting for the next QBR.

02

Every number you'd defend at the executive review

Your team re-runs anything, extends anything, overrides anything. No black boxes, no dashboard-rolled-up numbers the data can't validate, no "trust the AI."

03

Reads your data, not just the claims system and the EHR

Claims plus member enrollment, EHR-derived, pharmacy, referral, contract, and quality data — read together. The patterns the claims system can't see (because it only sees adjudication) and the patterns the EHR can't see (because it only sees the encounter) surface when your data is read end-to-end. Open source, AGPL v3. DecisionBox meets you on the stack you already run.

For your security and compliance review

What Healthcare & Life Sciences security teams ask first

How Enterprise handles it

Does our data move?

No. DecisionBox only reads it where it is, and can run inside your own environment, on-prem or air-gapped.

What can the AI see?

Only what you allow. Personal and sensitive data is hidden before the AI sees anything.

Which AI does it use?

The one your company approved, in your cloud account or on your own servers.

Can we audit it?

Every action is recorded: who, what, when and under which rule.

Videos

See DecisionBox at work

All videos
Product tourThe AI analyst that finds what nobody askedA two-minute tour: discovery, validation, Ask and reports on a real marketplace dataset.
DecisionBox for business · Episode 1How to read a finding, and how much to trust itThe numbers, the validation verdict and the evidence behind a finding, before you share it.
DecisionBox for business · Episode 4From finding to decision: read a recommendationThe expected impact, the steps, the findings behind it and its validation.

The next executive review, with the cohort shifts already mapped.

Let's run it on your data.